Celyad SA (CYAD): Price and Financial Metrics
CYAD Price/Volume Stats
| Current price | $0.47 | 52-week high | $3.07 |
| Prev. close | $0.53 | 52-week low | $0.46 |
| Day low | $0.47 | Volume | 49,000 |
| Day high | $0.53 | Avg. volume | 1,137,243 |
| 50-day MA | $0.77 | Dividend yield | N/A |
| 200-day MA | $1.19 | Market Cap | 10.62M |
CYAD Stock Price Chart Interactive Chart >
Celyad SA (CYAD) Company Bio
Celyad SA is a leader in engineered cell therapy treatments with clinical programs initially targeting indications in cardiology and oncology. The company was founded in 2004 and is based in Mont-Saint-Guibert, Belgium.
CYAD Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -87.89% |
| 5-year | -95.10% |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | -86.53% |
| 2021 | -53.08% |
| 2020 | -25.14% |
| 2019 | -42.62% |
Continue Researching CYAD
Want to see what other sources are saying about Celyad Sa's financials and stock price? Try the links below:Celyad Sa (CYAD) Stock Price | Nasdaq
Celyad Sa (CYAD) Stock Quote, History and News - Yahoo Finance
Celyad Sa (CYAD) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...